Dr. Thomas T. Su, MD, PhD

Dr. Su practices at Verdugo Dermatology in Glendale, California.

Dr. Su's NPI, 1346417276, was assigned on May 9, 2008. Dr. Su graduated from David Geffen School of Medicine at UCLA in 2004. Dr. Su's California license number on file is A94221.

Dr. Su's primary practice is Verdugo Dermatology, at 3600 N Verdugo Rd Suite 210 Suite 210, Glendale, CA 91208-1258. The practice phone is (818) 658-2300.

Dr. Su's primary practice is Verdugo Dermatology in Glendale, California. The medical group on file is Verdugo Dermatology. Dmand AI also links Dr. Su to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Su practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Su's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Su is board certified in dermatology by the American Board of Dermatology. Dr. Su has a license on file in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Su treats.

CMS data shows 7,145 Medicare services from Dr. Su across 24 procedure codes in 2024, for 1,397 Medicare patients. Medicare paid $611,224 for them. Every service was in an office.

CMS counts 1,397 Medicare patients who saw Dr. Su in 2024. The largest group is 65 to 74, with 566 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Su's median patient age at 60, with 53% women.

In 2024, Dr. Su wrote 3,169 Medicare Part D claims for 732 patients. 96% of them were for generic drugs. CMS names the drug for 3,024 of them, across 35 drugs with 11 or more claims each, at $564,691 in total drug cost. In 2023, CMS named 2,399 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Su for performance year 2024, reported as part of a group. Dr. Su accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,546 procedures of removal of skin lesions by Dr. Su, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Su, published from 2008 to 2015. The most frequent topics are Signal Transduction, Cyclic AMP-Dependent Protein Kinases and Mice, Transgenic. Dr. Su has published most often in Proc Natl Acad Sci U S A. Dr. Su's most frequent co-author is David J. Rawlings.

CMS Open Payments shows 646 general payments to Dr. Su from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,658.

Dr. Su graduated from David Geffen School of Medicine at UCLA in 2004.

Dr. Su is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.